Small Pharma Price To Book vs. EBITDA

DMTTFDelisted Stock  USD 0.05  0.0009  1.80%   
Based on the key profitability measurements obtained from Small Pharma's financial statements, Small Pharma may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Small Pharma's ability to earn profits and add value for shareholders.
For Small Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Small Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Small Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Small Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Small Pharma over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Please note, there is a significant difference between Small Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Small Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Small Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Small Pharma EBITDA vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Small Pharma's current stock value. Our valuation model uses many indicators to compare Small Pharma value to that of its competitors to determine the firm's financial worth.
Small Pharma is one of the top stocks in price to book category among its peers. It also is one of the top stocks in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Small Pharma's earnings, one of the primary drivers of an investment's value.

Small EBITDA vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Small Pharma

P/B

 = 

MV Per Share

BV Per Share

 = 
1.15 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Small Pharma

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(22.47 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Small EBITDA Comparison

Small Pharma is currently under evaluation in ebitda category among its peers.

Small Pharma Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Small Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Small Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Small Pharma's change in net profit over the period of time. It can combine multiple indicators of Small Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. The company was incorporated in 2015 and is headquartered in London, the United Kingdom. Small Pharma is traded on OTC Exchange in the United States.

Small Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Small Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Small Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Small Pharma's important profitability drivers and their relationship over time.

Use Small Pharma in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Small Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Small Pharma will appreciate offsetting losses from the drop in the long position's value.

Small Pharma Pair Trading

Small Pharma Pair Trading Analysis

The ability to find closely correlated positions to Small Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Small Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Small Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Small Pharma to buy it.
The correlation of Small Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Small Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Small Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Small Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Small Pharma position

In addition to having Small Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Heavy Metals Thematic Idea Now

Heavy Metals
Heavy Metals Theme
Companies involved in mining, production, and distribution of various industrial metals and minerals. The Heavy Metals theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Heavy Metals Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Small OTC Stock

If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences